Search

STERIS PLC

Suletud

SektorTervishoid

232.91 -1.24

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

231.86

Max

235.98

Põhinäitajad

By Trading Economics

Sissetulek

-19M

201M

Müük

-96M

1.5B

P/E

Sektori keskmine

29.065

57.002

Aktsiakasum

2.59

Dividenditootlus

1.06

Kasumimarginaal

13.466

Töötajad

17,937

EBITDA

-331M

349M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+16.81% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

1.06%

2.22%

Järgmine tulemuste avaldamine

4. nov 2026

Järgmine dividendimakse kuupäev

25. sept 2026

Järgmine aktsia dividendi kuupäev (ex-date)

3. sept 2026

Turustatistika

By TradingEconomics

Turukapital

1B

23B

Eelmine avamishind

234.15

Eelmine sulgemishind

232.91

Uudiste sentiment

By Acuity

34%

66%

117 / 340 Pingereas Healthcare

STERIS PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. aug 2026, 22:01 UTC

STERIS plc shares are lower in after-market hours amid concerns about consumer sentiment following an unexpected drop in U.S. retail sales for July.

13. aug 2026, 23:46 UTC

STERIS plc shares are lower in after-market hours, continuing a trend of declines since Thursday's close. No specific news was identified to explain the move.

12. aug 2026, 20:06 UTC

News

STERIS plc shares are lower as first-quarter results show a modest decline. The company announced a $600 million investment in a new manufacturing center.

11. aug 2026, 20:01 UTC

Shares of STERIS plc are lower today, breaking a recent trend of higher daily closes. No specific news was identified for the decline.

10. aug 2026, 19:43 UTC

News
Correlated Moves

STERIS shares are trading higher as Piper Sandler raised its price target to $275, despite mixed analyst ratings and target adjustments from UBS and KeyCorp.

7. aug 2026, 20:02 UTC

News

Piper Sandler raised STERIS plc's price target to $275, supporting positive sentiment. The stock advanced after earlier session weakness, reflecting strong buying interest.

6. aug 2026, 20:03 UTC

News

STERIS plc reported Q2 sales of $1.49 billion and adjusted EPS of $2.59, exceeding expectations. Shares are lower despite the results amid high trading volume.

5. aug 2026, 22:02 UTC

News

STERIS plc shares lower in after-market hours as FY2027 EPS guidance widens, missing estimates, and first-quarter sales fall short of expectations.

4. aug 2026, 20:07 UTC

News

STERIS shares are higher today, supported by broader market trends and a decline in crude oil prices. Earnings results are due August 5, 2026.

3. aug 2026, 20:06 UTC

News

STERIS plc shares are higher ahead of its Q1 2027 earnings announcement. Analysts expect earnings of $2.49 per share and revenue of $1.4949 billion.

31. juuli 2026, 19:26 UTC

Social Media
News

Shares of STERIS plc are lower despite a dividend increase announcement. UBS initiated coverage with a buy rating and a target price of $275.

30. juuli 2026, 18:51 UTC

STERIS plc is lower today, driven by weakness in the Health Care Equipment sub-sector. The stock reached a session low earlier this morning.

29. juuli 2026, 20:08 UTC

Shares of STERIS plc are higher today, supported by overall market strength and notable gains in oil prices amid escalating geopolitical tensions.

28. juuli 2026, 20:13 UTC

STERIS plc shares are trading higher in after-market hours, continuing a trend of gains and remaining significantly above the 20-day moving average.

27. juuli 2026, 20:06 UTC

STERIS plc shares are higher today, reflecting gains since Friday's close, despite pulling back from an earlier session high. No specific news was identified.

24. juuli 2026, 18:06 UTC

STERIS plc shares are higher during Friday's session, having reached an early peak. No specific company news was identified to explain the movement.

21. juuli 2026, 19:06 UTC

STERIS plc is declining as Health Care Equipment sub-sector weakness weighs on shares during Tuesday's session amid unusual volatility and significant sector downward movement.

20. juuli 2026, 18:41 UTC

STERIS plc shares are lower today, continuing a downward trend since Friday. The stock remains near the upper end of its one-month trading range.

Võrdlus sarnastega

Hinnamuutus

STERIS PLC Prognoos

Hinnasiht

By TipRanks

16.81% tõus

12 kuu keskmine prognoos

Keskmine 272.5 USD  16.81%

Kõrge 275 USD

Madal 270 USD

Põhineb 3 Wall Streeti analüütiku instrumendi STERIS PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

2

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

117 / 340 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat